Bailard’s Chemed CHE Stock Holding History

Bailard’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$652K	Hold	1,400	–	–	0.01%	467
2026 Q1	$529K	Hold	1,400	–	–	0.01%	469
2025 Q4	$599K	Sell	1,400 -900	-39%	-$392K	0.01%	433
2025 Q3	$1.03M	Hold	2,300	–	–	0.02%	328
2025 Q2	$1.12M	Sell	2,300 -21	-0.9%	-$12K	0.03%	308
2025 Q1	$1.43M	Hold	2,321	–	–	0.04%	259
2024 Q4	$1.23M	Hold	2,321	–	–	0.03%	275
2024 Q3	$1.39M	Sell	2,321 -125	-5%	-$70.9K	0.04%	264
2024 Q2	$1.33M	Hold	2,446	–	–	0.04%	258
2024 Q1	$1.57M	Sell	2,446 -25	-1%	-$15.2K	0.04%	251
2023 Q4	$1.44M	Sell	2,471 -37	-1%	-$20.7K	0.04%	247
2023 Q3	$1.3M	Buy	2,508 +35	+1%	+$18.2K	0.04%	243
2023 Q2	$1.34M	Buy	2,473 +173	+8%	+$94.6K	0.05%	235
2023 Q1	$1.24M	Hold	2,300	–	–	0.04%	238
2022 Q4	$1.17M	Buy	+2,300	New	+$1.12M	0.04%	238

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Bailard's CHE Position: Q2 2026 in Review

Bailard held its Chemed (CHE) position steady in Q2 2026 at 1,400 shares worth $652K. The position accounts for 0.01% of the portfolio, ranked #467.

Bailard first reported a position in CHE in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.57M in Q1 2024. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Bailard held 1,400 shares of Chemed worth $652K as of Q2 2026.
Bailard left its Chemed share count unchanged in Q2 2026.
Chemed made up 0.01% of Bailard's portfolio in Q2 2026, its #467 holding.
Bailard first reported a position in Chemed in Q4 2022 and has held it in 15 quarters since.
Bailard's Chemed position peaked at $1.57M in Q1 2024.
530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.